Title: Coeliac Disease: Diagnosis
1Coeliac DiseaseDiagnosis Management
- Dr Sameer Zar MBBS MRCP PhD
- Epsom St Helier NHS Trust
2Coeliac Disease
- Celiac disease (also known as gluten-sensitive
enteropathy or nontropical sprue) is an
immune-mediated inflammation of the small
intestine caused by sensitivity to dietary gluten
and related proteins in genetically sensitive
individuals. - The grains that contain the triggering proteins
are wheat, barley, and rye there is some
controversy as to whether oats also can cause the
disease
3Factors to Consider in the Diagnosis of Coeliac
Disease
- Prevalence of disease
- Who is susceptible to developing the disease?
- Limitations of diagnostic tests
- Risks of coeliac disease and delayed diagnosis
- Benefits of treatment of disease
- What leads to over or under diagnosis?
4Prevalence of coeliac Disease
- Traditionally, highest prevalence was in western
Ireland (1300) with lower values in other
European countries (11000), and the USA
(15000) - Use of screening tests indicate a higher
prevalence with values of 1100 - 1300 in most
genetically susceptible populations - However, it is estimated that less than 10-15 of
current cases of coeliac disease are diagnosed
5Elevated Risk of coeliac Disease
- 1st and 2nd degree relatives
- Downs syndrome (12)
- Type I DM (3-8)
- Autoimmune thyroid disease (5)
- Symptomatic iron deficiency anaemia (10-15)
- Asymptomatic iron deficiency anaemia (3-6)
- Microscopic colitis (15-27)
- IBS (3-5)
- Chronic fatigue syndrome (2)
- Osteoporosis (1-3)
6Who develops coeliac Disease?Genetic and other
Factors
- 70 concordance in twins
- 10-15 prevalence in first degree relatives
- Other factors involved since most with these
haplotypes do not get coeliac disease - Other genetic factors genes on chromosomes 6,
16 - Environmental factors Infectious agents
- Cytokines released during Infection Affecting
APCs (e.g., dendritic cells) - Cross-reactive amino acid sequences Adenovirus,
H. pylori
Coeliacs
- Increased frequency of HLA haplotypes
- DR3-DQ2
- DR5/7-DQ2
- DR4-DQ8
7Many and varied Presentations
- Classic Coeliac disease of childhood
- Late Onset GI symptoms
- Altered bowel habit
- Bloating,
- Dyspepsia
- Abdominal discomfort
- Anaemia (iron, folate, B12), coagulopathy
- Asymptomatic coeliac disease (often in relatives)
- Latent Coeliac Disease
8The clinical spectrum of coeliac disease
9Extra-intestinal Manifestations
- Haematological features
- Fe deficiency Anaemia
- Folate deficiency
- B12 deficiency
- Skin diseases
- Dermatitus herpetiformus
- Gynaecological and Obstetric conditions
- Miscarriages
- IUGR
- Infertility
10Extra-intestinal Manifestations
- Musculoskeletal features
- Osteopenic bone disease
- Osteomalacia
- Short stature
- Enamel defects
- Neuropsychiatric disorders
- Peripheral neuropathy
- Ataxia
- Migraines
- Cerebral calcifications
- Fatigue
- Irritability, Depression
11Associated Conditions
- Autoimmune endocrine disorders
- DM type I
- Autoimmune thyroid disease
- Addisons disease
- Autoimmune connective tissue disorders
- Rheumatoid arthritis
- Alopecia areata
- Sjogrens syndrome
- SLE
12Associated Conditions
- Hepatobiliary conditions
- Elevated transaminases
- Primary sclerosing cholangitis
- Autoimmune cholangitis
- Primary biliary cirrhosis
- Other
- Lymphocytic gastritis
- Microscopic colitis
- Downs syndrome, Turners syndrome
- IgA deficiency, IgA nephropathy
13Diagnosis
- Characteristic histological findings
- Clinical, serological, and in some cases,
histological response to a gluten free diet - Rarely, observe clinical and histological
response to gluten challenge - Some controversy as to whether biopsy is needed
in all cases but remains the standard of care
14Coeliac Disease Diagnostic criteria
- Major Criteria
- Consistent small bowel Bx
- Positive IgA hTTG serology
- Other Criteria
- Clinical response to GFD
- After serology bx
- Subjective
- Less reliable than IgA TTG serology histology
- Histologic response to GFD
- Relapse with gluten challenge
15Dietary Response to a Gluten Free Diet Is this
Diagnostic?
- Placebo response in IBS up to 70
- Gluten (increased prolamines) is hard to digest
- Gluten free diet often eliminates other dietary
factors - Symptomatic response to gluten free diet,
especially a transient response, does not imply
the diagnosis is coeliac disease
16Serologic Tests in Adults
Test Sensitivity Specificity
AGA IgA lt 80 in 50 gt 80 in most
AGA IgG Variable Non-specific
EMA IgA 96-97 MO, 90 HUV 100 MO, HUV
tTG IgA 90 GP, 98HR 95 GP, 98 HR
tTG IgG 40 98
17Development of New Serological Tests
- tTG (TG2) has a third function involved in actin
rearrangement - Smooth muscle anti-actin antibodies may provide
another useful serological test in diagnosing
coeliac disease - Serum from coeliac with active disease
preferentially recognise deamidated gliadin
peptides - IgA and IgG antibodies to deamidated gliadin
peptides (DGP) show promise as more sensitive and
specific tests than IgA and IgG AGA
18What are the Best Serological Tests for Screening?
- Depends on prevalence in and age of population
being examined - Overall, tTG IgA is the recommended test to
screen for disease but sensitivity varies with
lower levels reported in routine practice - EMA IgA is helpful when positive
- tTG, EMA less sensitive for milder histologic
stages - AGA no longer used as a first line antibody test
but AGDP has high sensitivity, specificity
19Complicated coeliac sprue
- Complicated sprue Pain/diarrhoea in spite of
gluten free diet, long period without diet,
history of small intestinal carcinoma or
lymphoma, anaemia, pos FOBT - 87 endoscopic signs of coeliac sprue
- 45 unexpected findings
- 21 Ulcerations
- 1 Small bowel carcinoma
- 1 Submucosal tumour
- 1 Ulcerated nodular Mucosa
- 1 Polyp
- 1 Stricture
- 1 Intussusception
Culliford et al. (2005) GIE 6255 (n 47)
20Coeliac disease Diagnosis
- Villous atrophy (duodenum) total/
subtotal/partial increased number of
intraepithelial lymphocytes (IEL) - Antibodies
- Anti-endomysial IgA
- Anti-transglutaminase IgA
- sensitivity/specificity gt 95
- Response (clinical /histological) to a
gluten-free diet
HLA DQ2/8 difficult case Consensus NIH
2004Consensus 2004
21Spectrum of Histopathology
22Are Biopsies the Gold Standard?
- False Positives
- Other conditions that cause epithelial changes
and/ore increased inflammation (peptic
duodenitis, bacterial overgrowth, enteric
infection, tropical sprue) - False Negatives
- Subtle findings, insufficient sample, patchy
disease, distal disease
23Other causes of Villous Atrophy
- Tropical sprue
- Zollinger-Ellison syndrome
- Common variable immunodeficiency
- Autoimmune enteropathy
- Other immunodeficiency states (usually apparent
clinically)
- Bacterial overgrowth
- Crohn's disease
- Cow's milk protein intolerance (children)
- Eosinophilic gastroenteritis
- Giardiasis
- Lymphoma
- Peptic duodenitis
- Post gastroenteritis
24HLA DQ Screening Tests
- Increased frequency of certain HLA haplotypes in
coeliac disease - DR3-DQ2 or DR5/7-DQ2 95
- DR4-DQ8 5
- Only HLA DQ2 or DQ8 positive subjects are at risk
of getting coeliac disease screening PCR tests
are available
- Risk of coeliac disease and HLA status
- General populations 1.0
- DQ2 homozygous-31X
- DQ2/DQ8 positive-14X
- DQ8 homozygous-10X
- DQ2 heterozygous-10X
- DQ8 heterozygous-2X
- DQ2 and DQ8 negative- 0.1X
25Diagnosis of Coeliac Disease
26Risks of coeliac disease and Delayed Diagnosis
- Manifestation of malabsorption
- Anaemia, osteopenia
- Decreased QOL
- Infertility, miscarriages, IUGR
- Malignancy
- Refractory coeliac disease
- Small increase in mortality
27Malignant Complications
- Enteropathy Associated T cell lymphoma (EATCL)
- Other lymphomas
- Small bowel adenocarcinoma
- Oropharyngeal cancer
- Oesophageal squamous cell cancer
- Other malignancies
28Malignant Complications
- Important to note that malignancies with the most
increased risk in coeliac disease are rare
cancers in the general population - NHL 0.5-1 per 1,000,000/yr in western pop
- SB adenoCa 0.6-0.7 per 100,000/yr
- Few studies show increased risk of CRC
- Breast cancer risk is reduced in some studies
29Prognosis
- Generally good prognosis
- Small increase in death rate returns to baseline
in first few years after diagnosis - Increased mortality in malabsorptive
presentations, if diagnosis is delayed, and in
those poorly compliant with diet - Main cause of excess death is lymphoma
30Mortality in coeliac Disease
Mortality 95 CI
5 yr survival rate same -
SMR 2.0 1.5-2.7
SMR 2.0 1.8-2.1
SMR 70.9 IBD 36.6-123.9
HR 1.31 1.13-1.51
31Response to Treatment
- Clinical improvement in 2 weeks in 70, by 6
weeks in most - Serological improvement by 4-6 weeks
- Histologic improvement in up to 2 or more years
- Gaining weight above ideal BMI
- Constipation
- Falling off the diet and getting ill again
32Failure to respond to dietary therapy
- Dietary Indiscretion
- Unintentional OR Intentional
- Co-existent conditions
- Lactose intolerance
- Small bowel bacterial overgrowth
- Pancreatic insufficiency
- Microscopic colitis
- IBD
- IBS
- Original diagnosis insecure
- Refractory Coeliac disease
33Refractory Coeliac Disease
- Type I
- Collagenous sprue
- Stricturing and ulcerative coeliac sprue
- Type II
- Clonal T cell expansion (CD3, CD8-)
- Treatment
- Corticosteroids (including budesonide)
- Azathioprine
- Infliximab
- Elemental or parenteral nutrition
- Screen for Enteropathy associated T cell lymphoma
34Why a Gluten Free Diet?
- Probably benefits overall cancer risk
- Improves unexplained infertility
- Ameliorates osteoporosis
- Corrects iron deficiency
- Improved QOL even for those detected by screening
- However, others report decreased QOL adhering to
a GFD - GFD is beneficial for preventing, reversing
and/or treating some complications
35Future Management Strategies
- Alter introduction of gluten during infancy,
reduce amount of gluten in infant diets - Breast feeding
- Modify gluten molecules (endopeptidases)
- Genetically modified or less toxic wheat strains
- Inhibit zonulin which regulates intestinal TJs
- Immunotherapy
- Block tTG
- Block HLA DQ2 (DQ8)
- Block T cells or TCR
36What is the Downside to the Over Diagnosis?
- The gluten free diet (GFD)
- Eating out of the home
- Peer pressure for children, teens
- Less acceptable taste, texture of foods
- Cost, availability, labelling
- New therapies on the horizon but are unlikely to
substitute for a GFD - Unclear long term benefit of GFD for latent and
asymptomatic cases detected by screening - Issues related to insurance, genetic testing, QOL
37Factors leading to Over Diagnosis
- Many patients are at risk
- Every IBS patient may have coeliac disease
- Increased patient awareness
- The wannabe coeliac
- Over sensitive, non-specific serology
- Over-interpretation of biopsies
- Screening of relatives, other asymptomatic
populations at risk
38Relatives Who and How to Screen
- Index case has proven coeliac disease
- Relative in interested in being screened
- Relative is willing to undergo diagnostic testing
- Relative is willing to undergo treatment
- Relative will derive benefit from treatment
- If relative is symptomatic, approach is
diagnostic not screening
39Relatives Who and How to Screen
Relative is an appropriate candidate?
Yes - get genetic testing First degree
relatives risk Unknown HLA 10-15 DQ2 or DQ8
- 20-30
No counsel relative and family
HLA DQ2 or 8 positive, check serology
HLA-DQ2 and 8 negative not at risk for coeliac
tTG IgA positive Perform OGD Bx
tTG IgA negative Repeat every few years
40Factors Leading to Under Diagnosis
- Disease presentation
- Classical form less prevalent now
- Other presentations not always considered as
manifestations of coeliac disease - Associations of coeliac disease with autoimmune
and other disorders not always recognised. - Awareness and understanding of disease by medical
practitioners - Use of less sensitive serological assays
- Diagnosis delayed by 11 years in survey data
- Cases continue to be missed in clinical practice
41Take Home Message
- Coeliac disease is not rare (1 in 100-300)
- It can present in many ways and is associated
with autoimmune diseases - Public awareness and medical recognition of
coeliac disease can vary - Diagnostic tests perform well but have
limitations - Together, these factors contribute to both over
and under diagnosis of coeliac disease - Implications of this situation are currently
unknown!
42What to Do with the Patient on a Gluten Free Diet
without Biopsy?
43Management of Coeliac disease
- Evaluate coeliac associated nutritional
deficiencies - FBC IrongtFolategtB12 deficiency
- 25-OH vitamin D /- PTH
- Treat deficiencies with GF supplements until
replete - Consider associated disorders (DH, thyroid
disease) - Educate regarding CD risk in 1o 2o relatives
- Refer for expert dietary counselling
- Gluten free diet
- Lactose free diet for 6/12?
- Monitor clinical serologic response (at 6 12
months) - Consider bone mineral density testing at 12 months
44Is screening for coeliac disease justified in
IBS patients?
IgA TTG positive True positive 11 False positive
1
Ig TTG negative but IgG or IgA AGA
positive True positive 3 False positive 51
Sanders et al. Lancet 2001